VERA CIK: 1831828

Vera Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−34.4
FY22:
−90.9
FY23:
−102
FY24:
−167
FY25:
−315
(positive)
Change from FY21 to FY25
millions USD
FY21:
−34.2
FY22:
−87.3
FY23:
−92.2
FY24:
−144
FY25:
−292
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.6
FY22:
−89.1
FY23:
−96.0
FY24:
−152
FY25:
−300
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.6
FY22:
−89.1
FY23:
−96.0
FY24:
−152
FY25:
−300

All amounts in millions USD Data sources:SEC EDGARTwelve Data